Publications

19

May, 2017

The Challenge of Treating Children with Hepatitis C Virus Infection. A new article by the PENTAHep team

 

The state of the art and the future perspectives of treatment of chronic hepatitis C virus infection in children has been summarized in an article recently published by the PENTAHep team in Journal of Pediatric Gastroenterology, Hepatology and Nutrition. The article is fruit of and provides an extensive overview of the recent PENTAHep activities and strategies.

 

Read

19

Apr, 2017

Immune repopulation after HAART in previously untreated HIV-1 infected children.

Tags:

Authors: Gibb DM, Newberry A, Klein N, de Rossi A, Grosch-Woerner I, Babiker A.

Published in:Lancet. Vol 355. England2000:1331-1332.

Read

18

Apr, 2017

Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruption” has been accepted for publication in AIDS

 

Authors: Ananworanich J, Melvin D, Ramos Amador JT, Childs T, Medin G, Boscolo V, Compagnucci A, Kanjanavanit S, Montero S, Gibb DM, on behalf of the PENTA 11 study group.

Published in: AIDS: 24 April 2016 – Volume 30 – Issue 7 – p 1075–1081

Read

18

Apr, 2017

Impact of NFV and its active metabolite M8 trough levels on virologic response from primary HIV-1 vertically infected children treated with d4T, ddI and NFV in the PENTA 7 study.

 

Authors: Compagnucci A, Saidi Y, Faye A, Ciria Calavia L, Gibb DM, Girard S, Quernin MH, Harper L, Giaquinto G, Debré M, Weigel R, Giacomet V, Aboulker JA, Jacqz-Aigrain EWalker AS

Published in: 2nd IAS Conference on HIV Pathogenesis and Treatment, 13-16 July Paris. Poster 1095

Read

12

Apr, 2017

Post-licensing safety of fosamprenavir in HIV-infected children in Europe.

 

Authors: Judd A, Duong T, Galli L, Goetghebuer T, Ene L, Noguera Julian A, Ramos Amador JT, Pimenta JM, Thorne C, Giaquinto C on behalf of the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord

Published in: Pharmacoepidemiology and Drug Safety 2013; 23(3): 321-325.

Read

1

Mar, 2017

The European Paediatric Mycology Network (EPMyN): Towards a Better Understanding and Management of Fungal Infections in Children

 

The European Paediatric Mycology Network (EPMyN) was launched in 2014 to create a European platform for research and education in the field of paediatric mycology. The EPMyN aims to address the lack of paediatric specific evidence and knowledge needed to (1) improve the management and outcome of invasive fungal infections in children and neonates and to (2) enhance and develop paediatric antifungal stewardship programmes.

Author: Adilia Warris

Published in: This article is published with open access at Springerlink.com

Read

24

Feb, 2017

Qualitative study of the BREATHER trial (Short Cycle antiretroviral therapy): is it acceptable to young people living with HIV?

 

Authors: Bernays S, Paparini S, Seeley J, Namukwaya Kihika S, Gibb D, Rhodes T.

Published in:BMJ Open. 2017;7(2):e012934

 

Read

27

Dec, 2016

Safety of zidovudine/lamivudine scored tablets in children with HIV infection in Europe and Thailand.

 

Published in: European Journal of Clinical Pharmacology, in press.

Read

20

Nov, 2016

Tuberculosis in HIV-infected children in Europe, Thailand and Brazil: paediatric TB-HIV EuroCoord study

 

Authors: Turkova A, Chappell E, Chalermpantmetagul S, et al.

Published in: Int J Tuberc Lung Dis 2016, 20:1448-1456.

Read

11

Nov, 2016

Interventions to improve treatment, retention and survival outcomes for adolescents with perinatal HIV-1 in high- and middle-income countries: Moving on up.

 

Authors: Judd A, Sohn A, Collins J.

Published in: Current Opinion in HIV and AIDS 2016; 11(5): 477-486

Read